Anti-warburg effect of rosmarinic acid via miR-155 in gastric cancer cells

Drug Design, Development and Therapy

Volumn 9, Issue , 2015, Pages 2695-2703

  Han, Shuai ^a   Yang, Shaohua ^a   Cai, Zhai ^a   Pan, Dongyue ^a   Li, Zhou ^a   Huang, Zonghai ^a   Zhang, Pusheng ^a   Zhu, Huijuan ^a   Lei, Lijun ^a   Wang, Weiwei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; MiR 155; MKN45; Rosmarinic acid; Warburg effect

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTIC ACID; MICRORNA 155; ROSMARINIC ACID; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 1; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; CINNAMIC ACID DERIVATIVE; DEPSIDE; MICRORNA; MIRN155 MICRORNA, HUMAN;

ANAEROBIC GLYCOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; GASTRIC CANCER CELL LINE; GENE EXPRESSION; GENE TARGETING; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; DRUG SCREENING; GENETICS; GLYCOLYSIS; INFLAMMATION; METABOLISM; NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CINNAMATES; DEPSIDES; GLYCOLYSIS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; STAT3 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84929593832     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S82342     Document Type: Article

References (33)

1. Sawayama H, Ishimoto T, Sugihara H, et al. Clinical impact of the Warburg effect in gastrointestinal cancer (review). Int J Oncol. 2014; 45(4):1345–1354.
2. Simonnet H, Alazard N, Pfeiffer K, et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis. 2002;23(5):759–768.
3. Moll UM, Schramm LM. P53 – an acrobat in tumorigenesis. Crit Rev Oral Biol Med. 1998;9(1):23–37.
4. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A.1993;90(9):4304–4308.
5. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721–732.
6. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–741.
7. Baiula M, Bedini A, Baldi J, Cavet ME, Govoni P, Spampinato S. Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy. Drug Des Devel Ther. 2014;8:745–757.
8. Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15(2):425–430.
9. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899.
10. Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011;21(1):103–115.
11. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
12. Vaughan RA, Garcia-Smith R, Dorsey J, Griffith JK, Bisoffi M, Trujillo KA. Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells. Int J Cancer. 2013;133(10):2504–2510.
13. Sahu A, Rawal N, Pangburn MK. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b. Biochem Pharmacol. 1999;57(12):1439–1446.
14. Xu Y, Jiang Z, Ji G, Liu J. Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. Planta Med. 2010;76(10):956–962.
15. Body JJ. Effectiveness and cost of bisphosphonate therapy in tumor bone disease. Cancer. 2003;97(3 Suppl):859–865.
16. Wu HP, Wang HL, Zhang Z, et al. [Analyze on the component of rosmarinic acid in Prunella vulgaris and its effect on alpha-glycosidase activity]. Zhong Yao Cai. 2011;34(11):1712–1715. Chinese.
17. Qiao S, Li W, Tsubouchi R, et al. Rosmarinic acid inhibits the formation of reactive oxygen and nitrogen species in RAW264.7 macrophages. Free Radic Res. 2005;39(9):995–1003.
18. Israf DA, Khaizurin TA, Syahida A, Lajis NH, Khozirah S. Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-kappaB nuclear translocation and Ikappa-B phosphorylation in RAW 264.7 macrophage cells. Mol Immunol. 2007;44(5):673–679.
19. Shen K, Liang Q, Xu K, et al. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol. 2012;84(3):320–330.
20. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8(6):519–530.
21. Marusawa H, Jenkins BJ. Inflammation and gastrointestinal cancer: an overview. Cancer Lett. 2014;345(2):153–156.
22. McGirt LY, Adams CM, Baerenwald DA, Zwerner JP, Zic JA, Eischen CM. Mir-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma. J Invest Dermatol. 2014;134(4):1101–1107.
23. Yuan CX, Zhou ZW, Yang YX, et al. Inhibition of mitotic aurora kinase a by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells. Drug Des Devel Ther. 2015;9:487–508.
24. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134(5):703–707.
25. Madhok BM, Yeluri S, Perry SL, Hughes TA, Jayne DG. Targeting glucose metabolism: an emerging concept for anticancer therapy. Am J Clin Oncol. 2011;34(6):628–635.
26. Gordo J, Maximo P, Cabrita E, et al. Thymus mastichina: chemical constituents and their anti-cancer activity. Nat Prod Commun. 2012;7(1):1491–1494.
27. Rosen DG, Mercado-Uribe I, Yang G, et al. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer. 2006;107(11):2730–2740.
28. Zhang JJ, Wang YL, Feng XB, Song XD, Liu WB. Rosmarinic acid inhibits proliferation and induces apoptosis of hepatic stellate cells. Biol Pharm Bull. 2011;34(3):343–348.
29. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009;139(4):693–706.
30. Yang Y, Peng W, Tang T, et al. MicroRNAs as promising biomarkers for tumor-staging: evaluation of MiR21 MiR155 MiR29a and MiR92a in predicting tumor stage of rectal cancer. Asian Pac J Cancer Prev. 2014;15(13):5175–5180.
31. Chiang Y, Song Y, Wang Z, et al. Microrna-192, -194 and -215 are frequently downregulated in colorectal cancer. Exp Ther Med. 2012; 3(3):560–566.
32. Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer. 2012;131(3):683–691.
33. Kim YW, Kim EY, Jeon D, et al. Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. Drug Des Devel Ther. 2014;8:293–314.